IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Neochem Bio Solutions IPO is a Book Building listing on NSE SME exchange, with an ipo size of ₹ [●] Cr. The company is based in Ahmedabad and caters to Chemical sector. Vivro Financial Services is the merchant banker of Neochem Bio Solutions IPO. It is a SME Upcoming IPO which filed its Draft Red Herring Prospectus (DRHP) on 1st August 2025.
Neochem Bio Solutions IPO posted revenues of ₹ 84.17 Cr. and PAT of ₹ 7.75 Cr. in FY25 on annualised basis.
Revenue:
₹ 84.17 Cr.
EBITDA Margin:
17.92
% 
Net Worth: ₹ 19.75 Cr.
Market Capitalisation:
[●]
P/E:
[●]
P/BV: [●]
EV/EBITDA: 2.36 times
Financial results of Neochem Bio Solutions IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | FY25 | FY24 | FY23 | ||
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 78.89 | 64.05 | 50.60 | ||
| Net Worth | 19.75 | 12.00 | 8.05 | ||
| Total Debt | 35.61 | 33.31 | 26.23 | ||
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
84.17 | 61.14 | 48.14 | ||
EBITDA
EBITDA on annualised basis |
15.08 | 6.83 | 4.81 | ||
PAT
PAT on annualised basis |
7.75 | 1.80 | 1.07 | ||
Neochem Bio Solutions IPO PAT Margin is 9.21 % , ROCE (Return on Capital Employed) is 41.67 % as per latest financial. The below table shows Neochem Bio Solutions IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | FY25 | FY24 | FY23 |
|---|---|---|---|
| EBITDA Margin (%) | 17.92 | 11.17 | 9.99 |
| PAT Margin (%) | 9.21 | 2.94 | 2.22 |
| EPS (₹) | 6.64 | 1.90 | 2.03 |
| ROE (%) | 39.24 | 15.00 | 13.29 |
| ROCE (%) | 41.67 | 21.46 | 17.46 |
| ROA (%) | 9.82 | 2.81 | 2.11 |
| Debt to Equity | 1.80 | 2.78 | 3.26 |
The market Capitalisation of Neochem Bio Solutions IPO is ₹ [●] crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Neochem Bio Solutions IPO prospectus highlights an Return on Equity (ROE) of 39.24 % , Return on Assets (ROA) of 9.82 %, and an EBITDA Margin of 17.92 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Neochem Bio Solutions IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Neochem Bio Solutions IPO is ₹ [●] Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Neochem Bio Solutions IPO has a Price-to-Earnings (PE) ratio of [●], indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Neochem Bio Solutions IPO reported revenue of ₹ 84.17 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Neochem Bio Solutions IPO provide insights into sales growth, market demand, and business scalability.
Neochem Bio Solutions recorded an EBITDA of ₹ 15.08 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Neochem Bio Solutions Profit After Tax (PAT) is ₹ 7.75 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 84.17 Cr.
EBITDA Margin:
17.92
%
Net Worth: ₹ 19.75 Cr.
Market Capitalisation:
[●]
P/E:
[●]
P/BV: [●]
EV/EBITDA:
[●]
Neochem Bio Solutions operates in Chemical and . The Issue is listed on NSE SME in Aug, 2025. Neochem Bio Solutions IPO size was with Issue price of .
Merchant Banker(s) of Neochem Bio Solutions IPO: Vivro Financial Services Private Limited
Neochem Bio Solutions IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Neochem Bio Solutions IPO listed at a listing price of against the offer price of .
The current market price of Neochem Bio Solutions is .
Why Us?
